Showing results (601-610 of 778) with videos related to

Sort By:
Pageof 78
Diabetes|June 5, 2013
ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapyErica Rurali, Marina Noris, Antonietta Chianca, et al.
Blood Advances|December 1, 2021
C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19Sistiana Aiello, Sara Gastoldi, Miriam Galbusera, et al.
Transplantation|February 24, 2007
DnIKK2-transfected dendritic cells induce a novel population of inducible nitric oxide synthase-expressing CD4+CD25- cells with tolerogenic propertiesSistiana Aiello, Paola Cassis, Linda Cassis, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 14, 2008
Successful split liver-kidney transplant for factor H associated hemolytic uremic syndromeJeffrey M Saland, Benjamin L Shneider, Jonathan S Bromberg, et al.
Frontiers in Immunology|July 7, 2025
C3d-targeted complement inhibitors to correct complement dysregulation in aHUS patientsValeria Guaschino, Donata Santarsiero, Sara Gastoldi, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 4, 2016
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in EuropeMarianna Cavazza, Yllka Kodra, Patrizio Armeni, et al.
Kidney International Reports|June 20, 2024
Corrigendum to "An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD" [Kidney International Reports Volume 9, Issue 2, February 2024, Pages 249-256]Jonathan Taylor, Richard Thomas, Peter Metherall, et al.
Kidney International Reports|February 12, 2024
An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKDJonathan Taylor, Richard Thomas, Peter Metherall, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 7, 2016
Social/economic costs and quality of life in patients with haemophilia in EuropeMarianna Cavazza, Yllka Kodra, Patrizio Armeni, et al.
Journal of the American Society of Nephrology : JASN|April 6, 2007
Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trialWouter B A Eijkelkamp, Zhongxin Zhang, Giuseppe Remuzzi, et al.
Pageof 78